Author:
Binkley Elaine M.,Schachat Andrew P.
Publisher
Springer International Publishing
Reference45 articles.
1. Kumar V, Abbas A, Aster JC. Robbins and Cotran pathologic basis of disease: Chapter 13: Diseases of white blood cells, Lymph nodes, spleen, and thymus. 9th ed. El Sevier, Philadelphia, PA; 2015.
2. Lawrence MT, Stephen JM, Maxine AP. Current medical diagnosis and treatment. 38 ed. Appleton and Lange, New York, NY; 1999.
3. Schrover RJ, Adena MA, De Abreu LR, Prince HM, Seymour JF, Wonder MJ. Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phase. Leuk Lymphoma. 2006;47(6):1069–81.
4. Sasaki K, Strom SS, O’Brien S, et al. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol. 2015;2(5):e186–93.
5. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–78.